How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs
Thuy Nguyen
◽
W. David Bradford
◽
Kosali Simon
Abby Alpert
◽
Sarah Dykstra
◽
Mireille Jacobson
2016 ◽
Vol 35
(6)
◽
pp. 1045-1051
◽
Yuhua Bao
◽
Yijun Pan
◽
Aryn Taylor
◽
Sharmini Radakrishnan
◽
Feijun Luo
◽
...
Abby Alpert
◽
Sarah Dykstra
◽
Mireille Jacobson
Adam C. Pomerleau
◽
Lewis S. Nelson
◽
Jason A. Hoppe
◽
Matthew Salzman
◽
Paul S. Weiss
◽
...
2017 ◽
Vol 18
(5)
◽
pp. 823-824
◽
2015 ◽
Vol 50
(4)
◽
pp. 277-278
◽
Fatimat Atanda
◽
Jieni Li
◽
Sang Kyu Cho
2018 ◽
Vol 38
(1)
◽
pp. 181-209
◽
Anca M. Grecu
◽
Dhaval M. Dave
◽
Henry Saffer
2018 ◽
Vol 54
(1)
◽
pp. 106-109
◽
Shabnam Sood
◽
Alicia Cowdrey
◽
Bikash Bhattarai
◽
Napatkamon Ayutyanont
◽
Gilbert Ramos
◽
...
2021 ◽
Vol 100
(1)
◽
pp. e24268
Amie Goodin
◽
Jungjun Bae
◽
Chris Delcher
◽
Joshua Brown
◽
Dikea Roussos-Ross